A business in context
BMY research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-09 | Massacesi Cristian | S · Sale | Common Stock, $0.10 par value | 6249.0 | 64.57 |
| 2026-09-01 | Short Bartie Wendy | M · Exercise / conversion | Common Stock, $0.10 par value | 1236.0 | 66.92 |
| 2026-09-01 | Short Bartie Wendy | F · Tax / exercise payment | Common Stock, $0.10 par value | 633.0 | 66.92 |
| 2026-09-01 | Short Bartie Wendy | M · Exercise / conversion | Restricted Stock Units | 1236.0 | 0.0 |
| 2026-08-25 | Holzer Phil M | S · Sale | Common Stock, $0.10 par value | 500.0 | 67.5 |
| 2026-08-01 | Massacesi Cristian | M · Exercise / conversion | Common Stock, $0.10 par value | 51172.0 | 0.0 |
| 2026-08-01 | Massacesi Cristian | F · Tax / exercise payment | Common Stock, $0.10 par value | 26175.0 | 65.31 |
| 2026-08-01 | Massacesi Cristian | M · Exercise / conversion | Restricted Stock Units | 51172.0 | 0.0 |
| 2026-08-01 | Gallman Cari | M · Exercise / conversion | Common Stock, $0.10 par value | 1061.0 | 0.0 |
| 2026-08-01 | Gallman Cari | F · Tax / exercise payment | Common Stock, $0.10 par value | 543.0 | 65.31 |
| 2026-08-01 | Gallman Cari | M · Exercise / conversion | Restricted Stock Units | 1061.0 | 0.0 |
| 2026-06-30 | Samuels Theodore R. II | A · Grant / award | Deferred Share Units | 889.45 | 57.62 |
| 2026-06-30 | McMullen Michael R. | A · Grant / award | Deferred Share Units | 607.43 | 57.62 |
| 2026-06-30 | Rice Derica W | A · Grant / award | Deferred Share Units | 672.51 | 57.62 |
| 2026-06-30 | Arduini Peter J | A · Grant / award | Deferred Share Units | 607.43 | 57.62 |
| 2026-06-30 | YALE PHYLLIS R | A · Grant / award | Deferred Share Units | 607.43 | 57.62 |
Identity & relationships
SEC issuer · 0000014272BRISTOL MYERS SQUIBB CO
Bristol-Myers Squibb (Japan)Bristol Myers Squibb (Canada)Bristol-Myers Squibb (India)Kosan BiosciencesBristol-Myers Squibb (Germany)
Search names and former names
View Wikidata identity and references ↗
- Bristol-Myers Squibb · alias · wikidata
- BMS · alias · wikidata
- Bristol Myers Squibb · alias · wikidata
- Bristol-Myers Squibb (Japan) · subsidiary · wikidata
- Bristol Myers Squibb (Canada) · subsidiary · wikidata
- Bristol-Myers Squibb (India) · subsidiary · wikidata
- Kosan Biosciences · subsidiary · wikidata
- Bristol-Myers Squibb (Germany) · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $48.30B | $51.88B |
| 2023-12-31 | $45.01B | $49.76B |
| 2022-12-31 | $46.16B | $53.14B |
| 2021-12-31 | $46.38B | $57.67B |
| 2020-12-31 | $42.52B | $55.35B |
| 2019-12-31 | $26.14B | $34.46B |
| 2018-12-31 | $22.56B | $30.27B |
| 2017-12-31 | $20.78B | $28.56B |